echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > J INTERN MED: Incidence and survival rate of hemophagocytic lymphohistiocytosis

    J INTERN MED: Incidence and survival rate of hemophagocytic lymphohistiocytosis

    • Last Update: 2021-12-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Hemophagocytic lymphohistiocytosis is a rare and highly inflammatory disease with a poor prognosis


    Recently, a research article was published in the Journal of Internal Medicine, an authoritative journal in the field of internal medicine.


    Researchers used population-based linked data from England's primary care, secondary care, cancer registry, and mortality database to determine the diagnosis of hemophagocytic lymphohistiocytosis between January 1, 2000 and December 31, 2016 Individual


    diagnosis

    Researchers identified 214 patients with hemophagocytic lymphohistiocytosis


    It can be seen that the diagnosis of hemophagocytic lymphohistiocytosis in England increased between 2000 and 2016


    Diagnosis of hemophagocytic lymphohistiocytosis in England increased between 2000 and 2016


    Original source:

    Joe West,et al.


    Incidence and survival of haemophagocytic lymphohistiocytosis: A population-based cohort study from England

    in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.